INRLF
Price
$4.28
Change
+$0.03 (+0.71%)
Updated
Sep 4 closing price
Capitalization
757.68M
ISCO
Price
$0.14
Change
+$0.01 (+7.69%)
Updated
Sep 3 closing price
Capitalization
1.12M
Interact to see
Advertisement

INRLF vs ISCO

Header iconINRLF vs ISCO Comparison
Open Charts INRLF vs ISCOBanner chart's image
Valneva SE
Price$4.28
Change+$0.03 (+0.71%)
Volume$600
Capitalization757.68M
International Stem Cell
Price$0.14
Change+$0.01 (+7.69%)
Volume$7.11K
Capitalization1.12M
INRLF vs ISCO Comparison Chart in %
Loading...
INRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INRLF vs. ISCO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INRLF is a Hold and ISCO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (INRLF: $4.28 vs. ISCO: $0.14)
Brand notoriety: INRLF and ISCO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INRLF: 35% vs. ISCO: 100%
Market capitalization -- INRLF: $757.68M vs. ISCO: $1.12M
INRLF [@Biotechnology] is valued at $757.68M. ISCO’s [@Biotechnology] market capitalization is $1.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INRLF’s FA Score shows that 0 FA rating(s) are green whileISCO’s FA Score has 1 green FA rating(s).

  • INRLF’s FA Score: 0 green, 5 red.
  • ISCO’s FA Score: 1 green, 4 red.
According to our system of comparison, both INRLF and ISCO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INRLF’s TA Score shows that 3 TA indicator(s) are bullish while ISCO’s TA Score has 1 bullish TA indicator(s).

  • INRLF’s TA Score: 3 bullish, 5 bearish.
  • ISCO’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, INRLF is a better buy in the short-term than ISCO.

Price Growth

INRLF (@Biotechnology) experienced а +0.59% price change this week, while ISCO (@Biotechnology) price change was +6.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INRLF($758M) has a higher market cap than ISCO($1.12M). INRLF YTD gains are higher at: 104.545 vs. ISCO (72.202). ISCO has higher annual earnings (EBITDA): 128K vs. INRLF (-20.38M). INRLF has more cash in the bank: 161M vs. ISCO (920K). ISCO has less debt than INRLF: ISCO (3.85M) vs INRLF (197M). INRLF has higher revenues than ISCO: INRLF (196M) vs ISCO (9.2M).
INRLFISCOINRLF / ISCO
Capitalization758M1.12M67,618%
EBITDA-20.38M128K-15,924%
Gain YTD104.54572.202145%
P/E RatioN/AN/A-
Revenue196M9.2M2,130%
Total Cash161M920K17,500%
Total Debt197M3.85M5,124%
FUNDAMENTALS RATINGS
INRLF vs ISCO: Fundamental Ratings
INRLF
ISCO
OUTLOOK RATING
1..100
9312
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4140
P/E GROWTH RATING
1..100
7988
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ISCO's Valuation (5) in the null industry is somewhat better than the same rating for INRLF (47). This means that ISCO’s stock grew somewhat faster than INRLF’s over the last 12 months.

ISCO's Profit vs Risk Rating (100) in the null industry is in the same range as INRLF (100). This means that ISCO’s stock grew similarly to INRLF’s over the last 12 months.

INRLF's SMR Rating (97) in the null industry is in the same range as ISCO (100). This means that INRLF’s stock grew similarly to ISCO’s over the last 12 months.

ISCO's Price Growth Rating (40) in the null industry is in the same range as INRLF (41). This means that ISCO’s stock grew similarly to INRLF’s over the last 12 months.

INRLF's P/E Growth Rating (79) in the null industry is in the same range as ISCO (88). This means that INRLF’s stock grew similarly to ISCO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INRLFISCO
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 24 days ago
65%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
78%
Bearish Trend 25 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ISCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNREX13.480.13
+0.97%
Dunham Real Estate Stock N
AMGAX17.910.10
+0.56%
Alger Mid Cap Growth A
ERHSX14.13N/A
N/A
Eaton Vance Worldwide Health Sci R
DOXWX16.14N/A
N/A
Dodge & Cox Global Stock X
PGEOX27.62-0.01
-0.04%
George Putnam Balanced A

INRLF and

Correlation & Price change

A.I.dvisor tells us that INRLF and BRTX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INRLF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INRLF
1D Price
Change %
INRLF100%
N/A
BRTX - INRLF
27%
Poorly correlated
-1.84%
SBMFF - INRLF
24%
Poorly correlated
N/A
ONCY - INRLF
21%
Poorly correlated
-1.85%
XFOR - INRLF
20%
Poorly correlated
-3.85%
ISCO - INRLF
4%
Poorly correlated
N/A
More

ISCO and

Correlation & Price change

A.I.dvisor tells us that ISCO and XBIT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISCO and XBIT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISCO
1D Price
Change %
ISCO100%
N/A
XBIT - ISCO
29%
Poorly correlated
-2.01%
INDP - ISCO
22%
Poorly correlated
-28.35%
CORT - ISCO
21%
Poorly correlated
-0.01%
BLTE - ISCO
20%
Poorly correlated
+0.92%
IVBXF - ISCO
5%
Poorly correlated
-0.82%
More